Lipid nanoparticles bound to anti-TIMP-1 antibodies show potential applications in glioma research. These nanoparticles can help target glioma cells, improving the effectiveness of treatment and potentially reducing side effects. By binding to anti-TIMP-1 antibodies, these lipid nanoparticles can more precisely locate and attack tumor cells, thereby enhancing anti-tumor activity.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-683CT-S(P) | Anti-Human TIMP-1 Recombinant Antibody scFv Fragment (MS-BW-3 ) | ELISA, BL | Human antibody |
TAB-683CT-F(E) | Anti-Human TIMP-1 Recombinant Antibody Fab Fragment (MS-BW-3 ) | ELISA, BL | Human antibody |
TAB-684CT-F(E) | Anti-Human TIMP-1 Recombinant Antibody Fab Fragment (MS-BW-28) | ELISA, BL | Human antibody |
TAB-685CT-F(E) | Anti-Human TIMP-1 Recombinant Antibody Fab Fragment (MS-BW-1) | ELISA, BL | Human antibody |
TAB-686CT-F(E) | Anti-Human TIMP-1 Recombinant Antibody Fab Fragment (MS-BW-27) | ELISA, BL | Human antibody |
There are currently no Customer reviews or questions for VS-1024-FY132. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.